Literature DB >> 7228450

Administration o gentamicin to obese patients.

S Korsager.   

Abstract

The relation beteen a single bolus dose of gentamicin and the subsequent concentration in serum was studied in 17 obese patients with 82.7% excess weight and in 10 normal-weight patients. The apparent volume of distribution (AVD) for gentamicin in the two groups was calculated. In the obese group the AVD (17.7%) was found to be significantly lower than in the normal-weight group (23.2%). The AVD for the adipose tissue and the lean body mass was calculated to be 10.3% and 31.0%, respectively. The uptake of gentamicin in adipose tissue was found to be 43.7% of the uptake in the total body mass of normal-weight patients. A formula which indicates an adjudged body weight is recommended when the proper dose of gentamicin for obese patients is calculated. The formula is recommended only in cases of severe obesity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7228450

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  15 in total

1.  Effect of age on the intracortical accumulation kinetics of gentamicin in rats.

Authors:  D Beauchamp; P Gourde; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

2.  Intravenous Push Administration of Antibiotics: Literature and Considerations.

Authors:  Samantha Spencer; Heather Ipema; Patricia Hartke; Courtney Krueger; Ryan Rodriguez; Alan E Gross; Michael Gabay
Journal:  Hosp Pharm       Date:  2018-03-08

3.  Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy.

Authors:  Grégoire Wuerzner; Murielle Bochud; Vittorio Giusti; Michel Burnier
Journal:  Obes Facts       Date:  2011-06-06       Impact factor: 3.942

Review 4.  Preventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens.

Authors:  Teena Chopra; Jing J Zhao; George Alangaden; Michael H Wood; Keith S Kaye
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2010-06       Impact factor: 2.217

Review 5.  Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Authors:  R de Groot; A L Smith
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

Review 6.  Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.

Authors:  D T Bearden; K A Rodvold
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

7.  Gentamicin volume of distribution as a power function of body weight.

Authors:  F Keller
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

Review 8.  Drug disposition in obese humans. An update.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

9.  Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients.

Authors:  L A Bauer; W A Edwards; E P Dellinger; D A Simonowitz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 10.  Pharmacokinetics of drugs in obesity.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.